Novartis Gains Rights To Debio 025

Novartis has gained rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent, currently in phase IIb development for the treatment of hepatitis C. Debio 025 has...

Published: 09-Feb-2010

Alliance Pharma To Acquire Cambridge Laboratories

Alliance Pharma has conditionally agreed to acquire Cambridge Laboratories (Ireland) and Cambridge Laboratories (together the 'Vendors'), for total consideration of between £14.3m and £16.4m, plus the...

Published: 08-Feb-2010

AnaptysBio Seals Pact With Merck

AnaptysBio has entered into a strategic collaboration with Merck & Co, through an affiliate, to develop novel antibody therapeutics for a specified disease target. ...

Published: 08-Feb-2010

Merz Launches Denzapine In Ireland

Merz Pharma (Merz) has launched Denzapine, generic version of Clozapine in Ireland. Clozapine is an antipsychotic medication. The product is available in the UK since February 2004, reported medical n...

Published: 07-Feb-2010

DxS Enters Pact With Pfizer

Pfizer and DxS, a wholly owned subsidiary of Qiagen have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the...

Published: 05-Feb-2010

BioMarin To Take Over LEAD Therapeutics

BioMarin has entered into a stock purchase agreement to acquire LEAD Therapeutics, a drug discovery and early stage development company with key compound, LT-673, an orally available poly (ADP-ribose)...

Published: 05-Feb-2010

GSK Names New President Of GSK Japan

GlaxoSmithKline (GSK) has appointed Philippe Fauchet as president of GSK Japan. Mr Fauchet will report to Marc Dunoyer, who takes the new role as chairman of GSK Japan. Mr Dunoyer will continue to tak...

Published: 04-Feb-2010

Ipsen, Debiopharm Launch Cancer Drug In France

Ipsen and its partner, Debiopharm, have launched Decapeptyl LP 22.5mg, a sustained release drug for treatment of locally-advanced or metastatic hormone-dependent prostate cancer, in France. The compan...

Published: 04-Feb-2010

Mintaka Foundation for Medical Research Receives £2.7m For HIV Research

The Mintaka Foundation for Medical Research in Geneva has received fund of £2.7m from Wellcome Trust, London. The fund will be used to proceed an anti-HIV microbicide known as 5P12-RANTES, to clinical...

Published: 04-Feb-2010

Pfizer Q4 Net Income Increases 188%

Pfizer has reported financial results for fourth-quarter and full-year 2009. Fourth-quarter 2009 revenues were $16.5 billion, an increase of 34% compared to $12.3 billion in the year-ago quarter. For ...

Published: 04-Feb-2010

more news...